Similar Articles
1281 Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials
1282 Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound
1283 Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
1284 Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines
1285 Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
1286 Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis
1287 ALK gene copy number gain and its clinical significance in hepatocellular carcinoma
1288 Epirubicin, Cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma
1289 Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis
1290 Transplant benefit for patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA